UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2284) 2284
Newsletter (23) 23
Book Chapter (9) 9
Magazine Article (3) 3
Dissertation (2) 2
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1754) 1754
science & technology (1607) 1607
life sciences & biomedicine (1571) 1571
male (1381) 1381
female (1359) 1359
busulfan - administration & dosage (1346) 1346
adult (1016) 1016
hematology (1012) 1012
transplantation (951) 951
busulfan (931) 931
middle aged (890) 890
oncology (768) 768
biological and medical sciences (721) 721
medical sciences (710) 710
adolescent (707) 707
immunology (557) 557
child (536) 536
transplantation conditioning - methods (516) 516
cyclophosphamide - administration & dosage (488) 488
stem cells (482) 482
aged (443) 443
antineoplastic combined chemotherapy protocols - therapeutic use (435) 435
busulfan - adverse effects (433) 433
child, preschool (431) 431
busulfan - therapeutic use (416) 416
hematopoietic stem cells (413) 413
hematopoietic stem cell transplantation (406) 406
transplantation, homologous (401) 401
treatment outcome (395) 395
animals (393) 393
antineoplastic agents (353) 353
vidarabine - analogs & derivatives (338) 338
biophysics (337) 337
bone marrow transplantation (326) 326
retrospective studies (318) 318
infant (310) 310
pharmacology. drug treatments (310) 310
chemotherapy (297) 297
hematopoietic stem cell transplantation - methods (296) 296
combined modality therapy (282) 282
busulfan - pharmacokinetics (275) 275
disease-free survival (272) 272
anesthesia. intensive care medicine. transfusions. cell therapy and gene therapy (267) 267
transplantation conditioning (267) 267
transfusions. complications. transfusion reactions. cell and gene therapy (264) 264
bone marrow, stem cells transplantation. graft versus host reaction (261) 261
stem cell transplantation (254) 254
young adult (254) 254
vidarabine - administration & dosage (249) 249
dosage and administration (234) 234
cyclophosphamide (227) 227
health aspects (227) 227
survival analysis (220) 220
transplantation, autologous (216) 216
risk factors (215) 215
survival rate (213) 213
hematopoietic stem cell transplantation - adverse effects (211) 211
research (209) 209
cancer (207) 207
follow-up studies (206) 206
mice (197) 197
care and treatment (196) 196
graft vs host disease - prevention & control (190) 190
transplantation conditioning - adverse effects (190) 190
hematology, oncology and palliative medicine (189) 189
bone marrow (186) 186
melphalan - administration & dosage (184) 184
analysis (180) 180
hematologic and hematopoietic diseases (174) 174
immunosuppressive agents - administration & dosage (173) 173
busulfan - pharmacology (172) 172
dose-response relationship, drug (172) 172
time factors (172) 172
pharmacokinetics (169) 169
recurrence (165) 165
pediatrics (164) 164
antineoplastic combined chemotherapy protocols - administration & dosage (163) 163
antineoplastic agents, alkylating - administration & dosage (162) 162
pharmacology & pharmacy (161) 161
remission induction (155) 155
whole-body irradiation (154) 154
leukemia, myeloid, acute - therapy (153) 153
busulfan - analogs & derivatives (149) 149
abridged index medicus (148) 148
antineoplastic combined chemotherapy protocols - adverse effects (145) 145
myeloablative agonists - administration & dosage (145) 145
graft vs host disease - etiology (143) 143
leukemia (143) 143
cyclophosphamide - therapeutic use (142) 142
cyclophosphamide - adverse effects (140) 140
fludarabine (137) 137
etoposide - administration & dosage (135) 135
drug administration schedule (129) 129
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (128) 128
prognosis (124) 124
antimitotic agents (122) 122
mortality (122) 122
prospective studies (122) 122
transplants & implants (121) 121
hematologic neoplasms - therapy (120) 120
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2190) 2190
Japanese (44) 44
German (28) 28
Russian (24) 24
French (21) 21
Chinese (16) 16
Spanish (16) 16
Polish (11) 11
Danish (3) 3
Portuguese (3) 3
Czech (2) 2
Hungarian (2) 2
Italian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 35, pp. 4167 - 4175
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. 500 - 514
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 16, pp. 3073 - 3079
busulfan | high‐dose chemotherapy | primary central nervous system lymphoma (PCNSL) | autologous stem cell transplantation (ASCT) | cyclophosphamide | thiotepa | high-dose chemotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Follow-Up Studies | Thiotepa - administration & dosage | Bacterial Infections - etiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Busulfan - administration & dosage | Lymphoma - therapy | Dacarbazine - analogs & derivatives | Adult | Female | Retrospective Studies | Dacarbazine - administration & dosage | Kaplan-Meier Estimate | Central Nervous System Neoplasms - therapy | Remission Induction | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Stem Cell Transplantation - methods | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mucositis - etiology | Methotrexate - administration & dosage | Aged | Temozolomide | Transplantation Conditioning | Stem Cell Transplantation - adverse effects | Chemotherapy | Usage | Care and treatment | Nervous system cancer | Thiotepa | Stem cells | Dosage and administration | Transplantation | Busulfan | Radiotherapy | Cancer | Brain | Toxicity | Central nervous system | Stem cell transplantation | Nervous system | Institutions | Confidence intervals | Cytarabine | Consolidation | Remission | Bacteria | Diagnosis | Conditioning | Methotrexate | Age | Autografts | Mucositis | Rituximab | Radiation therapy | Patients | Survival | Disease control | Lymphoma | Amplification | Cyclophosphamide | Index Medicus | Abridged Index Medicus
Journal Article
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 12/2011, Volume 46, Issue 12, pp. 1510 - 1518
Journal Article
Cancer, ISSN 0008-543X, 01/2015, Volume 121, Issue 2, pp. 226 - 233
Journal Article
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 23, Issue 3, pp. S403 - S403
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 12/2012, Volume 70, Issue 6, pp. 765 - 782
Medicine & Public Health | Leukemia | Etoposide | Oncology | Cancer Research | Conditioning therapy | Pharmacology/Toxicology | Allogeneic stem cell transplantation | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Humans | Busulfan - administration & dosage | Transplantation, Homologous | Stem Cell Transplantation | Antineoplastic Agents, Phytogenic - administration & dosage | Arabinonucleosides - administration & dosage | Anthracyclines - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Dose Fractionation | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Adenine Nucleotides - administration & dosage | Radiotherapy, Adjuvant | Leukemia, Myeloid, Acute - therapy | Antineoplastic Agents, Phytogenic - adverse effects | Severity of Illness Index | Etoposide - adverse effects | Leukemia - radiotherapy | Drug Administration Schedule | Carboplatin - administration & dosage | Etoposide - pharmacology | Leukemia - drug therapy | Leukemia - therapy | Etoposide - administration & dosage | Clinical Trials as Topic | Mucositis - chemically induced | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Leukemia - surgery | Antineoplastic Agents, Phytogenic - pharmacology | Lomustine - administration & dosage | Carmustine - administration & dosage | Allergy | Oncology, Experimental | Stem cells | Bone marrow | Dosage and administration | Transplantation | Research | Allergic reaction | Cancer | Index Medicus
Journal Article